Neogen (FRA:NG2) E10: €-0.09 (As of Feb. 2026)


FRA:NG2 Neogen Corp FRA:NG2
68 GF Score
Price €8.40
GF Value €10.73
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neogen E10?

Neogen FRA:NG2 +5.08% 68 E10 is €-0.09 as of Feb. 2026. GuruFocus rates FRA:NG2 with a GF Score™ of 68/100 and a GF Value™ of €10.73 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Neogen's adjusted earnings per share data for the three months ended in Feb. 2026 was €-0.068. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.09 for the trailing ten years ended in Feb. 2026.

During the past 12 months, Neogen's average E10 Growth Rate was -150.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Neogen was 58.70% per year. The lowest was 0.70% per year. And the median was 15.00% per year.

As of today (2026-07-11), Neogen's current stock price is €8.396. Neogen's E10 for the quarter that ended in Feb. 2026 was €-0.09. Neogen's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Neogen was 137.86. The lowest was 19.95. And the median was 83.01.


Neogen  (FRA:NG2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Neogen was 137.86. The lowest was 19.95. And the median was 83.01.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Neogen E10 Related Terms


Neogen E10 Historical Data

* Premium members only.

The historical data trend for Neogen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen E10 Chart

Neogen Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.48 0.45 0.44 -0.06

Neogen Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 -0.06 -0.06 -0.08 -0.09

FRA:NG2 vs UFPT, ALMR, BFLY: E10 Comparison

For the Medical Devices subindustry, Neogen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neogen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Neogen's Shiller PE Ratio falls into.


FRA:NG2
68GF Score
Neogen Corp FRA:NG2
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neogen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neogen's adjusted earnings per share data for the three months ended in Feb. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=-0.068/326.7850*326.7850
=-0.068

Current CPI (Feb. 2026) = 326.7850.

Neogen Quarterly Data

per share eps CPI Adj_EPS
201605 0.086 240.229 0.117
201608 0.087 240.849 0.118
201611 0.102 241.353 0.138
201702 0.094 243.603 0.126
201705 0.109 244.733 0.146
201708 0.097 245.519 0.129
201711 0.141 246.669 0.187
201802 0.130 248.991 0.171
201805 0.140 251.588 0.182
201808 0.126 252.146 0.163
201811 0.136 252.038 0.176
201902 0.110 252.776 0.142
201905 0.134 256.092 0.171
201908 0.126 256.558 0.160
201911 0.140 257.208 0.178
202002 0.105 258.678 0.133
202005 0.141 256.394 0.180
202008 0.127 259.918 0.160
202011 0.127 260.229 0.159
202102 0.099 263.014 0.123
202105 0.121 269.195 0.147
202108 0.136 273.567 0.162
202111 0.088 277.948 0.103
202202 0.044 283.716 0.051
202205 0.131 292.296 0.146
202208 0.049 296.171 0.054
202211 -0.186 297.711 -0.204
202302 0.037 300.840 0.040
202305 0.024 304.127 0.026
202308 0.009 307.026 0.010
202311 -0.018 307.051 -0.019
202402 -0.009 310.326 -0.009
202405 -0.023 314.069 -0.024
202408 -0.054 314.796 -0.056
202411 -1.978 315.493 -2.049
202502 -0.048 319.082 -0.049
202505 -2.502 321.465 -2.543
202508 0.146 323.976 0.147
202511 -0.061 324.122 -0.062
202602 -0.068 326.785 -0.068

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.09 mean?
Neogen (FRA:NG2) has a E10 of €-0.09 as of Feb. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Neogen and its competitors.
Is Neogen's E10 too high?
Neogen's current E10 is €-0.09. Overall, Neogen has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neogen's E10 compare to UFPT and ALMR?
Neogen's E10 of €-0.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Neogen and its competitors. Neogen's current E10 is €-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Modestly Undervalued. The stock's GF Value™ is €10.73, compared to a current price of €8.40 — trading 21.8% below its estimated fair value. The current E10 is €-0.09. Neogen's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Neogen (FRA:NG2), the current E10 is €-0.09 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be undervalued. The current stock price of €8.40 is trading 21.8% below its estimated GF Value™ of €10.73. GuruFocus considers Neogen to be Modestly Undervalued.

Key valuation signals for FRA:NG2:

  • E10: €-0.09
  • GF Value™: €10.73 vs. price of €8.40 (21.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
68GF Score

Get the complete analysis for FRA:NG2

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.40
Price
€10.73
GF Value